[Therapy of epilepsy: trends and effectiveness of new anticonvulsants].

Schweiz Arch Neurol Psychiatr (1985)

Abteilung für Elektroenzephalographie Neurologische Klinik Kantonsspital Basel.

Published: January 1996

New antiepileptic drugs such as vigabatrin, lamotrigine, gabapentin, oxcarbazepine and felbamate have been lately marketed. This article provides an overview, showing known modes of action, pharmacokinetics, efficacy, tolerability, interactions and indications. A table showing selected data of antiepileptic drugs is included.

Download full-text PDF

Source

Publication Analysis

Top Keywords

antiepileptic drugs
8
[therapy epilepsy
4
epilepsy trends
4
trends effectiveness
4
effectiveness anticonvulsants]
4
anticonvulsants] antiepileptic
4
drugs vigabatrin
4
vigabatrin lamotrigine
4
lamotrigine gabapentin
4
gabapentin oxcarbazepine
4

Similar Publications

Background: Paliperidone is a second-generation antipsychotic and the main active metabolite of risperidone, formulated to provide consistent therapeutic effects through an extended-release system, designed to provide consistent therapeutic effects through an extended-release formulation. While commonly used in clinical practice, switching from risperidone to paliperidone, particularly during valproate therapy, can pose challenges due to potential pharmacokinetic interactions that may increase the risk of extrapyramidal symptoms (EPS). Despite clinical observations suggesting these interactions, case reports documenting such adverse effects are scarce.

View Article and Find Full Text PDF

Adoptive cell therapies (ACT) have shown reduced efficacy against solid tumor malignancies compared to hematologic malignancies, partly due to the immunosuppressive nature of the tumor microenvironment (TME). ACT efficacy may be enhanced with pleiotropic cytokines that remodel the TME; however, their expression needs to be tightly controlled to avoid systemic toxicities. Here we show T cells can be armored with membrane-bound cytokines with surface expression regulated using drug-responsive domains (DRDs) developed from the 260-amino acid protein human carbonic anhydrase 2 (CA2).

View Article and Find Full Text PDF

Application and Mechanism of Action of a Ketogenic Diet in Antiepileptic Therapy.

ACS Chem Neurosci

January 2025

Department of Neurology, Ganzhou Hospital-Nanfang Hospital, Southern Medical University, Ganzhou, Jiangxi 341000, China.

Epilepsy is a chronic neurological disorder caused by abnormal discharges of neurons in the brain, which seriously affects the quality of life of patients. Although there are various drug treatments available, many epilepsy patients still experience seizures with the effect of drugs and develop refractory epilepsy. The ketogenic diet can treat drug-refractory epilepsy by regulating the body's metabolism and can enhance the quality of life by improving their cognition, behavior, and sleep quality.

View Article and Find Full Text PDF

Seizures are a frequent complication in glioma. Incidence of brain tumor-related epilepsy (BTRE) in high-grade glioma (HGG) is an estimated > 25% and in low-grade glioma (LGG) is approximately 72%. Two first-line antiseizure medications (ASMs) for BTRE include levetiracetam (LEV) and valproic acid (VPA).

View Article and Find Full Text PDF

[Psychological assessment of drug-resistant epilepsy patients: affective factors and social support].

Orv Hetil

January 2025

1 Szegedi Tudományegyetem, Bölcsészet és Társadalomtudományi Kar, Pszichológia Intézet, Kognitív- és Neuropszichológia Tanszék Szeged, Egyetem u. 2., 6725 Magyarország.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!